Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00296-020-04612-6 http://scihub22266oqcxt.onion/10.1007/s00296-020-04612-6 C7270517!7270517 !32500409     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32500409 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32500409 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Rheumatol+Int 2020 ; 40 (8 ): 1193-1213 Nephropedia Template TP {{tp|p=32500409 |t=2020. Implications of COVID-19 in pediatric rheumatology |pdf=|usr=}}{{32500409 }} gab.com Text Implications of COVID-19 in pediatric rheumatology JO: Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=32500409 #FOAvip COVID-19 (coronavirus disease 2019) pandemic caused by SARS-CoV-2, is a global public health issue threatening millions of lives worldwide. Although the infection is mild in most of the affected individuals, it may cause severe clinical manifestations such as acute respiratory distress syndrome or cytokine storm leading to death. Children are affected less, and most experience a milder disease. As rheumatologists, we deal with the uncontrolled response of the immune system, and most of the drugs we use are either immune modulators or immunosuppressants. Thus, the rheumatologists participate in the multidisciplinary management of COVID-19 patients. On the other hand, our patients with rheumatic diseases constitute a vulnerable group in this pandemic. In this review, a systematic literature search was conducted utilizing MEDLINE/PubMed and Scopus databases, and 231 COVID-19 patients with rheumatic diseases have been identified. Only one of these patients was a child. Among these, 9 (3.9%) died due to COVID-19. In light of the current data, the aspects of COVID-19 resembling rheumatic diseases, the possible reasons for why children are affected less severely, the hypothetic role of available vaccines in preventing COVID-19, the unique position of patients with rheumatic diseases in this pandemic, and the use of anti-rheumatic drugs in COVID-19 treatment are discussed. Twit Text FOAVip Implications of COVID-19 in pediatric rheumatology ????Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=32500409 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32500409 #FOAvip English Wikipedia <ref>{{Cite pmid|32500409 }}</ref> Implications of COVID-19 in pediatric rheumatology #MMPMID32500409 Batu ED ; Özen S Rheumatol Int 2020[Aug]; 40 (8 ): 1193-1213 PMID32500409 show ga COVID-19 (coronavirus disease 2019) pandemic caused by SARS-CoV-2, is a global public health issue threatening millions of lives worldwide. Although the infection is mild in most of the affected individuals, it may cause severe clinical manifestations such as acute respiratory distress syndrome or cytokine storm leading to death. Children are affected less, and most experience a milder disease. As rheumatologists, we deal with the uncontrolled response of the immune system, and most of the drugs we use are either immune modulators or immunosuppressants. Thus, the rheumatologists participate in the multidisciplinary management of COVID-19 patients. On the other hand, our patients with rheumatic diseases constitute a vulnerable group in this pandemic. In this review, a systematic literature search was conducted utilizing MEDLINE/PubMed and Scopus databases, and 231 COVID-19 patients with rheumatic diseases have been identified. Only one of these patients was a child. Among these, 9 (3.9%) died due to COVID-19. In light of the current data, the aspects of COVID-19 resembling rheumatic diseases, the possible reasons for why children are affected less severely, the hypothetic role of available vaccines in preventing COVID-19, the unique position of patients with rheumatic diseases in this pandemic, and the use of anti-rheumatic drugs in COVID-19 treatment are discussed. |*Betacoronavirus [MESH] |BCG Vaccine/immunology [MESH] |COVID-19 [MESH] |Child [MESH] |Coronavirus Infections/*drug therapy/prevention & control [MESH] |Female [MESH] |Humans [MESH] |Male [MESH] |Measles-Mumps-Rubella Vaccine/immunology [MESH] |Pandemics/prevention & control [MESH] |Pneumonia, Viral/*drug therapy/prevention & control [MESH] |Rheumatic Diseases/*drug therapy [MESH]Implications of COVID-19 in pediatric rheumatology (epmc).pdf DeepDyve Pubget Overpricing